View More Recent Stories

May 5, 2020 06:45AM Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
May 5, 2020 06:45AM Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
May 5, 2020 06:45AM Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
Apr 29, 2020 05:48AM Pfizer (PFE), BioTech (BNTX) Report Complete Patient Dosing in First Cohort of Ph. 1/2 Trial of COVID-19 vaccine candidates in Germany
Apr 29, 2020 03:42AM BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
Apr 22, 2020 05:00AM BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates
Apr 9, 2020 07:50AM Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
Apr 9, 2020 07:50AM Pfizer Advances Battle Against COVID-19 on Multiple Fronts
Apr 9, 2020 07:39AM Pfizer (PFE) and BioNTech (BNTX) Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
Apr 9, 2020 07:37AM Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
Mar 20, 2020 09:23AM Germany Trade & Invest: German Companies at the Heart of Coronavirus Vaccine Efforts
Mar 17, 2020 06:13AM Pfizer (PFE) and BioNTech SE (BNTX) Agree to Co-Develop Potential COVID-19 Vaccine
Mar 17, 2020 02:02AM Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
Mar 17, 2020 02:00AM Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine
Mar 13, 2020 03:26PM Pfizer (PFE) Outlines Five-Point Plan to Battle COVID-19
Mar 13, 2020 03:25PM Pfizer Outlines Five-Point Plan to Battle COVID-19
View More Recent Stories